Factors Affecting Non-Adherence to Secondary Stroke Prevention Therapy in Ischemic Stroke Patients

https://doi.org/10.22146/jmpf.34434

Zakky Cholisoh(1*), Hidayah Karuniawati(2), Tanti Azizah(3), Zaenab Zaenab(4), Laila Nur Hekmah(5)

(1) Faculty of Pharmacy, Universitas Muhammadiyah Surakarta
(2) Faculty of Pharmacy, Universitas Muhammadiyah Surakarta
(3) Faculty of Pharmacy, Universitas Muhammadiyah Surakarta
(4) Faculty of Pharmacy, Universitas Muhammadiyah Surakarta
(5) Faculty of Pharmacy, Universitas Muhammadiyah Surakarta
(*) Corresponding Author

Abstract


Stroke is cardiovascular disease that causes the world's highest disability and is the most prevalence disease after heart disease and cancer. Stroke is caused by circulatory disorders with 80% of the sufferers are diagnosed with ischemic stroke and 20% of them are diagnosed with hemorrhagic stroke. Patients who survive from the first stroke have high risk to have recurrent stroke. American Heart Association/American Stroke Association and Perhimpunan Dokter Spesialis Syaraf Indonesia recommend secondary stroke prevention therapy including antiplatelet/anticoagulant, antihypertensive agents, and antidislipidemia to minimalize the risk of recurrent stroke. Secondary stroke prevention therapy is only the first step. Patients need to be adhere to those therapies. The non-adherence will increase the risk of recurrent stroke. The study aimed to determine factors which causing the non-adherence to secondary prevention therapy in patients with ischemic stroke. This was a case control study with concecutive sampling method by interviewing patients who met the inclusion criterias i.e., had been diagnosed and were inpatients due to ischemic stroke, but in the time of interview patients were outpatients, patients were able to communicate and agree to participate in the study.Data was analized by bivariate / chi square test and multivariate logistic regression test. During the study period, 184 respondents met the inclusion criterias. Factors affecting non-adherence in the use of secondary prevention therapy were No one reminded to take medicine p = 0.03; OR 4.51, denial of the disease p = 0,036 OR 214, and tired of taking medicine p = 0,045 OR 1,97.

Keywords


ischemic stroke; recurrent stroke; secondery stroke therapy; non adherence

Full Text:

PDF


References

1. Kemenkes RI. Infodatin : Situasi Kesehatan Jantung. Jakarta Selatan; 2014. doi:10.1017/CBO9781107415324.004

2. Nasution LF. Stroke Non Hemoragik pada Laki-Laki Usia 65 Tahun. Medula Unila. 2013;1(3):1-9.

3. Favate AS, Younger DS. Epidemiology of Ischemic Stroke. Neurol Clin. 2016;34(4):967-980. doi:10.1016/j.ncl.2016.06.013

4. Dinata CA, Safrita Y, Sastri S. Gambaran Faktor Risiko dan Tipe Stroke pada Pasien Rawat Inap di Bagian Penyakit Dalam RSUD Kabupaten Solok Selatan Periode 1 Januari 2010 - 31 Juni 2012. J Kesehat Andalas. 2013;2(2):57-61.

5. Usrin I, Mutiara E, Yusad Y. Pengaruh Hipertensi Terhadap Kejadian Stroke Iskemik dan Stroke Hemoragik di Ruang Neurologi di Rumah Sakit Stroke Nasional (RSSN) Bukittingi Tahun 2011. 2013. doi:10.1002/ejic.201402692

6. Dipiro J, Talbert R, Yee GC, Matzke GR, Wells BG, Posey LM. Pharmacotherapy A Pathophysiologic Approach. McGraw-Hill Companies, New York. 2011;8th ed.

7. Furie KL, Kasner SE, Adams RJ, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke. 2011;42(1):227-276. doi:10.1161/STR.0b013e3181f7d043

8. Bangalore S, Schwamm L, Smith EE, et al. Secondary prevention after ischemic stroke or transient ischemic attack. Am J Med. 2014;127(8):728-738. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=medl&AN=24681258.

9. Hackam DG, Spence JD. Combining multiple approaches for the secondary prevention of vascular events after stroke: a quantitative modeling study. Stroke. 2007;38(6):1881-1885. doi:10.1161/STROKEAHA.106.475525

10. Yusuf S. Two decades of progress in preventing vascular disease. Lancet. 2002;360(9326):2-3. doi:10.1016/S0140-6736(02)09358-3

11. Karuniawati H, Ikawati Z, Gofir A. Pengaruh Pencegahan Sekunder Terhadap Kejadian Stroke Berulang Pada Pasien Stroke Iskemik Di Rsud. Dr. Moewardi Di Surakarta.

12. Prabhakaran S, Chong JY. Risk factor management for stroke prevention. Continuum (Minneap Minn). 2014;20(2 Cerebrovascular Disease):296-308. doi:10.1212/01.CON.0000446102.82420.64

13. Glader EL, Sjölander M, Eriksson M, Lundberg M. Persistent use of secondary preventive drugs declines rapidly during the first 2 years after stroke. Stroke. 2010;41(2):397-401. doi:10.1161/STROKEAHA.109.566950

14. De Schryver ELLM, Van Gijn J, Kappelle LJ, Koudstaal PJ, Algra A. Non-adherence to aspirin or oral anticoagulants in secondary prevention after ischaemic stroke. J Neurol. 2005;252(11):1316-1321. doi:10.1007/s00415-005-0858-0

15. Bushnell CD, Zimmer LO, Pan W, et al. Persistence with stroke prevention medications 3 months after hospitalization. Arch Neurol. 2010;67(12):1456-1463. doi:10.1001/archneurol.2010.190

16. Khan NA, Yun L, Humphries K, Kapral M. Antihypertensive drug use and adherence after stroke: Are there sex differences? Stroke. 2010;41(7):1445-1449. doi:10.1161/STROKEAHA.110.579375

17. Venketasubramanian N, Tan LCS, Sahadevan S, et al. Prevalence of stroke among Chinese, Malay, and Indian Singaporeans: A community-based tri-racial cross-sectional survey. Stroke. 2005;36(3):551-556. doi:10.1161/01.STR.0000155687.18818.13

18. Feigin VL, Lawes CMM, Bennett DA, et al. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol. 2003;2(1):43-53. doi:10.1016/S1474-4422(03)00266-7

19. World Health Organization(WHO). WHO - ADHERENCE TO LONG-TERM THERAPIES: EVIDENCE FOR ACTION. WHO. 2015:Cap XIII 107-114.

20. Putra IDGRC, Pinzon RT, Pramudita EA. Hubungan Antara Tingkat Kepatuhan Minum Obat Antiplatelet Aspirin Dengan Kejadian Stroke Iskemik Berulang Di RS Bethesda Yogyakarta. Media Farm. 2016;13(1):49-60. http://journal.uad.ac.id/index.php/Media-Farmasi/article/view/5742.

21. Makmun Syadullah, Miftahudin BGA. Faktor-Faktor yang Berhubungan dengan Kepatuhan Menjalani Rehabilitasi medik pada Pasien Stroke. 2017;8(49):1843-1852. doi:10.1002/adma.201605145

22. Dahlan S. Besar Sampel Dan Cara Pengambilan Sampel Dalam Penelitian Kedokteran Dan Kesehatan, Seri Evidence Based Medicine 2. 3rd ed. Jakarta: Salemba Medika; 2010.

23. Kabi GYCR, Tumewah R, Kembuan  mieke AHN. Sebaran Kebiasaan Merokok pada Pasien Stroke Iskemik yang di Rawat Inap di Bagian Neurologi RSU Prof. Dr. R. D. Kandou Manado Periode Juli 2012 - Juni 2013. 2015;3(April).

24. Lambert. Practice Guidelines: AHA/ASA Guidelines on Prevention of Recurrent Stroke - American Family Physician.

25. Sari Indah Permata. Faktor-Faktor Yang Berhubungan Dengan Terjadinya Stroke Berulang Pada Penderita Pasca Stroke. 2015:1-16.

26. Lin J, Sklar GE, Oh VM Sen, Li SC. Factors affecting therapeutic compliance: A review from the patient’s perspective. Ther Clin Risk Manag. 2008;4(1):269-286. doi:https://dx.doi.org/10.2147/TCRM.S1458

27. Dahlan S. Statistik Untuk Kedokteran Dan Kesehatan, Deskriptif, Bivariat, Dan Multivariat Dilengkapi Aplikasi Dengan Menggunakan SPSS, Seri Evidence Based Medicine. 5th ed. Jakarta: Salemba Medika; 2011.

28. Wang Y, Wu D, Wang Y, Ma R, Wang C, Zhao W. A survey on adherence to secondary ischemic stroke prevention. Neurol Res. 2006;28(1):16-20. doi:10.1179/016164106X91816

29. Pagès-Puigdemont N, Mangues MA, Masip M, et al. Patients’ Perspective of Medication Adherence in Chronic Conditions: A Qualitative Study. Adv Ther. 2016;33(10):1740-1754. doi:10.1007/s12325-016-0394-6

30. Department of Health National Audit Office. Progress in improving stroke care. London Station Off. 2010;(February):13. doi:10.1017/CBO9781107415324.004

31. Ownby RL, Hertzog C, Crocco E, Duara R. Factors related to medication adherence in memory disorder clinic patients. Aging Ment Heal. 2006;10(4):378-385. doi:10.1080/13607860500410011

32. Marshall IJ, Wolfe CDA, McKevitt C. Lay perspectives on hypertension and drug adherence: Systematic review of qualitative research. BMJ. 2012;345(7867). doi:10.1136/bmj.e3953

33. Chambers JA, O’Carroll RE, Hamilton B, et al. Adherence to medication in stroke survivors: A qualitative comparison of low and high adherers. Br J Health Psychol. 2011;16(3):592-609. doi:10.1348/2044-8287.002000



DOI: https://doi.org/10.22146/jmpf.34434

Article Metrics

Abstract views : 760 | views : 3735

Refbacks

  • There are currently no refbacks.


Copyright (c) 2018 JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice)

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

©Jurnal Manajemen dan Pelayanan Farmasi
Faculty of Pharmacy
Universitas Gadjah Mada
Creative Commons License
View My Stats